Biosimilar Development solution center

1. Thunderstruck By Antibody-Drug Conjugates 3/18/2025

   Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

2. The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly 3/3/2025

   In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

3. U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance 2/28/2025

   Joseph Pategou asks and answers, "Where does the U.S. biosimilar market stand now?"

4. Multi-Attribute Method Analysis In Biopharmaceutical Development 2/26/2025

   Analytics is a crucial element in biopharmaceutical development and manufacturing. Discover how Multi-Attribute Method (MAM) revolutionizes analytics to enhance quality control and regulatory compliance.

5. Emerging Trends In mAbs Manufacturing In 2025 And Beyond 2/11/2025

   Two key innovations — continuous perfusion in upstream processing and multicolumn chromatography in downstream processing — are having a profound impact on biologics manufacturing.

6. Clinical Regulatory Changes One Of Many Tailwinds For Biosimilars 2/10/2025

   With an projected global market value of $35.7 billion in 2025, biosimilars are slated for considerable growth opportunities, thanks in part to clinical regulatory changes.

7. Improving Bioprocess Monitoring And Control With Multivariate Data Analysis 12/9/2024

   Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.

8. Optimize Your RFP To Ensure Successful Biologic Development 11/5/2024

   Creating a thorough, comprehensive RFP will help a CDMO partner lay the foundation for a productive partnership, fulfill your goals, and help ensure future market success for your therapeutic.

9. Choose The Right CDMO To Guide Your Biologic To Regulatory Success 11/5/2024

   If you are wondering when to begin your CDMO search, the answer is simple: the sooner the better. Partnering with a CDMO early helps ensure later success.

10. 3 Ways To Maximize The Benefits Of Your CDMO Partnership 11/5/2024

    An experienced CDMO partner can help bridge the gap from lab scale to clinical and commercial scale while sharing the critical insights needed to launch a biologic manufacturing program.